Exanthema 
Welcome,         Profile    Billing    Logout  

2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Exanthema
PROCAPP, NCT01626781: A Randomized, Open-label Phase III Trial of MapisalĀ® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast Cancer

No Longer Available
3
Europe
Mapisal, Urea hand-foot cream
AIO-Studien-gGmbH
the Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With Capecitabine
 
 
NCT02149732: Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation

Available
N/A
RoW
cultivated oral mucosal epithelial sheet transplantation
Seoul National University Hospital, Ministry of Health & Welfare, Korea
Limbal Stem Cell Deficiency, Stevens-johnson Syndrome, Ocular Cicatricial Pemphigoid, Chemical Burn
12/16
12/16

Download Options